Archives
-
Ionomycin Free Acid for Calcium–FAK Workflows
2026-09-13
Use Ionomycin free acid as an acute calcium ion transport tool to test whether calcium-dependent proteolysis intersects with FAISL–FAK signaling in triple-negative breast cancer. The same reagent also supports distinct oocyte activation studies, but each application requires separate controls, dose finding, and endpoint validation.
-
Recombinant Human IL-15 Assay Workflows
2026-09-12
Build reproducible T-cell and NK-cell assays with a tag-free, low-endotoxin cytokine input. This guide translates product specifications into practical reconstitution, titration, assay, and troubleshooting workflows while placing emerging neuroimmune questions in the correct evidentiary context.
-
EZ Cap™ Firefly Luciferase mRNA Workflow
2026-09-11
Build sensitive translation, gene regulation, and delivery assays with a Cap1-structured firefly luciferase transcript. This practical guide connects RNase-aware handling and transfection design with lipid nanoparticle size selection for more reproducible in vitro and in vivo readouts.
-
Ceftolozane/Tazobactam: Evidence and Research Design
2026-09-10
Cho, Fiorenza, and Estrada review ceftolozane/tazobactam as an antipseudomonal cephalosporin–beta-lactamase inhibitor combination designed to address resistant gram-negative pathogens. The paper’s main contribution is its integrated analysis of PBP activity, resistance coverage, pharmacokinetics, pharmacodynamics, clinical indications, and safety, providing a framework for interpreting translational antibacterial evidence.
-
EZ Cap™ Cy5 EGFP mRNA: Dual-Readout Assay Guide
2026-09-10
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) is a Cy5-labeled mRNA reporter that separates cellular delivery from EGFP protein expression. Its Cap1 structure, 5-moUTP modification, and dual fluorescence support an mRNA delivery and translation efficiency assay, but fluorescent uptake alone does not prove productive cytosolic translation.
-
HCAR3 Structures Reveal Agonist Selectivity
2026-09-09
The 2025 PLOS Biology study defines how selective agonists recognize HCAR3/GPR109B and how subtle pocket differences distinguish HCAR3 from HCAR2/GPR109A. By combining cryo-EM structures with cAMP assays, the work provides a structural framework for lipid signaling pathway modulation and the design of HCAR3-directed research tools.
-
Salinomycin in Hepatocellular Carcinoma Research
2026-09-09
Salinomycin is a polyether ionophore antibiotic investigated as a multi-pathway research tool in hepatocellular carcinoma models. Product-described activity includes ABC transporter interference, Wnt/β-catenin signaling pathway inhibition, calcium elevation, growth suppression, and apoptosis-associated changes, but these findings do not establish clinical efficacy.
-
Nonivamide (Capsaicin Analog) Assays
2026-09-08
This scenario-based guide explains how Nonivamide (Capsaicin Analog), SKU A3278, can support reproducible TRPV1, viability, proliferation, and apoptosis workflows. It covers solvent control, stock preparation, assay interpretation, literature context, and practical product-selection criteria.
-
HR Repair Profiling Predicts Olaparib Response in MPM
2026-09-08
Borchert et al. linked homologous recombination repair defects, particularly BAP1-associated BRCAness, with olaparib sensitivity in malignant pleural mesothelioma models. Their combination of cell-line pharmacology and gene-expression profiling suggests a strategy for identifying patient subsets that may benefit from PARP inhibition, especially alongside cisplatin.
-
SCH772984 HCl: ERK1/2 Assay Guide
2026-09-07
This scenario-based guide explains how SCH772984 HCl (SKU B5866) can improve the design and interpretation of ERK-dependent viability, proliferation, and cytotoxicity assays. It covers solvent handling, controls, potency interpretation, pathway readouts, and practical criteria for selecting a reliable ERK1/2 inhibitor.
-
Brefeldin A: Reliable ER Stress Assay Workflows
2026-09-07
This scenario-driven guide explains how Brefeldin A, SKU B1400, can improve experimental reasoning in viability, proliferation, cytotoxicity, ER stress, and apoptosis workflows. It covers mechanism, assay compatibility, preparation, interpretation, and practical vendor-selection criteria without treating BFA-induced cytotoxicity as a nonspecific assay artifact.
-
Ionomycin Free Acid in FAK–TNBC Research
2026-09-05
A mechanistic and translational framework for using Ionomycin free acid to interrogate calcium-dependent regulation of the FAISL–FAK axis in triple-negative breast cancer, while distinguishing established evidence from testable experimental hypotheses.
-
Barley Leaf Senescence and Cathepsin-Like Proteases
2026-09-04
Schepetkin and Fischer show that developmental senescence in barley is accompanied by increased cathepsin B- and L-like protease activity, coordinated Rubisco loss, and induction of senescence-associated proteases. Their inhibitor, pH-profile, activity-probe, and immunoblotting strategy distinguishes broad cysteine-protease activation from the specific contribution of cathepsin B-like enzymes.
-
Meropenem trihydrate: Assay Reliability Guide
2026-09-04
A scenario-driven guide to using Meropenem trihydrate (SKU B1217) in bacterial resistance, cell viability, proliferation, and cytotoxicity workflows. It connects formulation data with practical controls and recent LC-MS/MS evidence to help researchers distinguish antimicrobial effects from assay artifacts.
-
N6-Methyl-dATP for DNA Fidelity Workflows
2026-09-03
N6-Methyl-dATP enables controlled tests of how adenine methylation affects polymerase recognition, incorporation, and replication accuracy. This workflow-focused guide connects cell-free nucleotide assays with AML transcriptional-network research while clearly separating validated evidence from hypothesis-generating applications.